Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

SEMA / IGF-1 LR3Check methods and identity

What separate Alzheimer’s studies measured for these two molecules

3 numbered sourcesSource years 2024, 2026

Peptides are short amino-acid chains connected by peptide bonds. Some activate receptors and change how cells handle signals. Semaglutide is a modified GLP-1 receptor agonist peptide. IGF-1 LR3 is an engineered growth-factor protein. Researchers have studied each in connection with Alzheimer’s disease in very different settings. The human semaglutide trials and an older IGF-1 LR3 mouse experiment show how the choice of outcome shapes the conclusion. [1, 2]

The evoke and evoke+ trials randomly assigned people with early symptomatic Alzheimer’s disease to oral semaglutide or placebo. The main comparison assessed change in a clinical scale that combines observations about cognition and daily function. At 104 weeks, neither trial found a significant difference in progression on that measure. These trials were designed to test the clinical outcome in people who already had early symptoms. [1]

In a separate study, investigators tested IGF-1 LR3 in male mice engineered to develop some features of Alzheimer’s disease. The researchers examined the animals’ behavior and brain tissue. They reported changes in certain amyloid plaque measurements, but they did not observe a significant preservation of cognitive function in their tests. Changes in tissue pathology and changes in performance were separate outcomes, even within this one experiment. [2]

Reading these findings together can help identify what was measured at each level. The mouse tissue findings concern a growth-factor analog in a particular model. The clinical scale findings concern a particular semaglutide formulation and population. Neither study included both molecules. There is no comparative clinical result for the catalog pair in these sources, and the investigated uses do not establish an Alzheimer’s indication. [1, 2, 3]

Sources

Original works cited in this article. Links open the external record in a new tab.

Shop SEMA / IGF-1 LR3

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice. Also available as Markdown or JSON.